IQVIA Holdings Inc. (0JDM.L)

215,89 -0,77 (-0,36%) Alla chiusura: 06:35PM GMT

IQVIA Holdings Inc.

2400 Ellis Road
Durham, NC 27703
United States
919 998 2000
https://www.iqvia.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 87.000

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Ari Bousbib	Chairman, President & CEO	8,33M	N/D	1961
Mr. Ronald E. Bruehlman	Executive VP & CFO	2,38M	N/D	1961
Mr. Eric M. Sherbet	Executive VP, General Counsel & Secretary	1,33M	N/D	1964
Mr. Kevin C. Knightly	President of Corporate Strategy & Enterprise Networks	1,32M	N/D	1961
Ms. Keriann Cherofsky	Senior VP, Corporate Controller & Principal Accounting Officer	N/D	N/D	1984
Dr. Jeffrey A. Spaeder	Senior VP, Global Chief Medical & Scientific Officer	N/D	N/D	N/D
Mr. Karl Guenault	Senior VP & Chief Information Officer	N/D	N/D	N/D
Mr. Nicholas Childs	Senior Vice President of Investor Relations & Treasury	N/D	N/D	N/D
Ms. Trudy Stein	Chief Human Resources Officer & Executive VP	N/D	N/D	N/D
Dr. Cynthia L. Verst	President of Design & Delivery Innovation	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.

Governance aziendale

L'ISS Governance QualityScore di IQVIA Holdings Inc. al 1 dicembre 2023 è 8. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 8; diritti degli azionisti: 6; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.